Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment

Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment

Abstract Epistaxis management on COVID‐19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nas...

Full description

Bibliographic Details
Main Authors: Samba Siva R. Bathula, Tyler Patrick, Luxman Srikantha
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Clinical Case Reports
Subjects:
COVID‐19
epistaxis
Merocel
surgicel
Online Access:https://doi.org/10.1002/ccr3.3137

Similar Items

Similar Items